Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-β1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses

Cancer Research

Volumn 69, Issue 19, 2009, Pages 7756-7766

  Xie, Yufeng ^a   Bai, Ou ^a   Yuan, Jinying ^a   Chibbar, Rajni ^a   Slattery, Karen ^a   Wei, Yangdou ^a   Deng, Yulin ^a   Xiang, Jim ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; LIPOCORTIN 5; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANTIBODY SPECIFICITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TUMOR CELL; TUMOR CELL CULTURE; TUMOR IMMUNITY; ULTRACENTRIFUGATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CLONAL ANERGY; EXOSOMES; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OVALBUMIN; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; THYMOMA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 70350218803     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0496     Document Type: Article

References (50)

1. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-579
2. Hao S, Moyana T, Xiang J. Review: cancer immunotherapy by exosome-based vaccines. Cancer Biother Radiopharm 2007;22:692-703. (Pubitemid 350059006)
3. Hao S, Bai O, Li F, Yuan J, Laferte S, Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 2007;120:90-102. (Pubitemid 44950474)
4. Zitvogel L, Regnault A, Lozier A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998;4:594-600. (Pubitemid 28237359)
5. Cho JA, Yeo DJ, Son HY, et al. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer 2005;114:613-622
6. Chen W, Wang J, Shao C, et al. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol 2006;36: 1598-1607 (Pubitemid 43942147)
7. Liu C, Yu S, Zinn K, et al. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function. J Immunol 2006;176:1375-1385 (Pubitemid 43134279)
8. Abusamra AJ, Zhong Z, Zheng X, et al. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol Dis 2005;35:169-173 (Pubitemid 41267045)
9. Kim SH, Lechman ER, Bianco N, et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 2005;174:6440-6448 (Pubitemid 40663838)
10. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Natl Acad Sci U S A 1996;93:2239-2244
11. Allera C, Lazzarini G, Patrone E, et al. The condensation of chromatin in apoptotic thymocytes shows a specific structural change. J Biol Chem 1997; 272:10817-10822 (Pubitemid 27181097)
12. Fonteneau JF, Larsson M, Bhardwaj N. Dendritic cell-dead cell interactions: implications and relevance for immunotherapy. J Immunother 2001;24: 294-304. (Pubitemid 32825861)
13. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;392:86-89 (Pubitemid 28150594)
14. Albert ML, Pearce SF, Francisco LM, et al. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 1998;188:1359-1368
15. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine- specific clearance of apoptotic cells. Nature 2000;405:85-90. (Pubitemid 30321820)
16. Aupeix K, Hugel B, Martin T, et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 1997;99:1546-1554 (Pubitemid 27163805)
17. Thery C, Boussac M, Veron P, et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001;166:7309-7318 (Pubitemid 32525606)
18. Gutwein P, Stoeck A, Riedle S, et al. Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells. Clin Cancer Res 2005;11: 2492-2501 (Pubitemid 40569445)
19. Winau F, Weber S, Sad S, et al. Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity 2006;24:105-117 (Pubitemid 43077204)
20. Winau F, Kaufmann SH, Schaible UE. Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell Microbiol 2004;6: 599-607. (Pubitemid 38812055)
21. Chen Z, Moyana T, Saxena A, Warrington R, Jia Z, Xiang J. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer 2001;93: 539-548 (Pubitemid 32701413)
22. Chan T, Chen Z, Hao S, et al. Enhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis. Cancer Gene Ther 2007;14:409-420 (Pubitemid 46425784)
23. Zhang X, Huang H, Yuan J, et al. CD4-8- dendritic cells prime CD4+ T regulatory 1 cells to suppress antitumor immunity. J Immunol 2005;175:2931-2937
24. Xiang J, Huang H, Liu Y. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen- presenting cells. J Immunol 2005;174:7497-7505 (Pubitemid 40806252)
25. Zou W. Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer 2005;5:263-274 (Pubitemid 40488632)
26. Nakamura K, Kitani A, Strober W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor β. J Exp Med 2001;194: 629-644 (Pubitemid 32844773)
27. Nakano N, Hosokawa H, Kohyama M, Hozumi N. NFAT- mediated expression of TGF-β1 in tolerant T cells. J Immunol 2007;178:3067-3075 (Pubitemid 46333187)
28. Restifo NP. Building better vaccines: how apoptotic cell death can induce inflammation and activate innate and adaptive immunity. Curr Opin Immunol 2000;12: 597-603.
29. Albert ML, Jegathesan M, Darnell RB. Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells. Nat Immunol 2001;2:1010-1017 (Pubitemid 33069495)
30. Ferguson TA, Herndon J, Elzey B, Griffith TS, Schoenberger S, Green DR. Uptake of apoptotic antigen-coupled cells by lymphoid dendritic cells and cross-priming of CD8(+) T cells produce active immune unresponsiveness. J Immunol 2002;168:5589-5595 (Pubitemid 34556139)
31. Maeda A, Schwarz A, Kernebeck K, et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 2005;174:5968-5976 (Pubitemid 40663783)
32. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008;8:279-289
33. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κ B pathway. Int Immunol 2000;12:1539-1546 (Pubitemid 30838184)
34. Reiter I, Krammer B, Schwamberger G. Cutting edge: differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. J Immunol 1999;163:1730-1732 (Pubitemid 29382166)
35. Scheffer SR, Nave H, Korangy F, et al. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 2003;103:205-211 (Pubitemid 35461512)
36. Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J Immunol 2003;171:5940-5947 (Pubitemid 37467212)
37. Gamrekelashvili J, Kruger C, von Wasielewski R, et al. Necrotic tumor cell death in vivo impairs tumor-specific immune responses. J Immunol 2007;178:1573-1580 (Pubitemid 46154628)
38. Klopp AH, Jhingran A, Ramdas L, et al. Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clinical outcome. Int J Radiat Oncol Biol Phys 2008;71:226-236
39. Chakraborty M, Abrams SI, Camphausen K, et al. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 2003;170:6338-6347 (Pubitemid 36682620)
40. Garnett CT, Palena C, Chakraborty M, Tsang KY, Schlom J, Hodge JW. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes. Cancer Res 2004;64: 7985-7994 (Pubitemid 39446933)
41. Reits EA, Hodge JW, Herberts CA, et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006;203:1259-1271 (Pubitemid 43736595)
42. Geiser AG, Kim SJ, Roberts AB, Sporn MB. Characterization of the mouse transforming growth factor-β 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol 1991;11:84-92.
43. Yang Y, Mumy M, Romeo D, Wakefield LM. Identification of the start sites for the 1.9- and 1.4-kb rat transforming growth factor-β1 transcripts and their effect on translational efficiency. Gene 1998;219:81-89 (Pubitemid 28470239)
44. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol 1998;16:137-161
45. Chen W, Frank ME, Jin W, Wahl SM. TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001;14:715-725 (Pubitemid 32592419)
46. Nakamura K, Yuh K, Sugyo S, Kuroki M, Shijo H, Tamura K. Unresponsiveness of peripheral T cells induced by apoptotic bodies derived from autologous T cells. Cell Immunol 1999;193:147-154 (Pubitemid 29228359)
47. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 2007;67:7458-7466 (Pubitemid 47214451)
48. Tisch M, Heimlich F, Daniel V, Opelz G, Maier H. Cellular immune defect caused by postsurgical radiation therapy in patients with head and neck cancer. Otolaryngol Head Neck Surg 1998;119:412-417 (Pubitemid 28467395)
49. Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW. External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing. Cancer Res 2004;64:4328-4337 (Pubitemid 38802440)
50. Gulley JL, Arlen PM, Bastian A, et al. Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer. Clin Cancer Res 2005;11:3353-3362 (Pubitemid 40627887)